Glycomet Trio Forte 2 Tablets

Glycomet Trio Forte 2 is an advanced triple-action anti-diabetic tablet containing Voglibose (0.2 mg), Glimepiride (2 mg), and Metformin Hydrochloride (1000 mg, sustained release).

It helps manage Type 2 Diabetes Mellitus by improving insulin response, reducing glucose absorption, and controlling liver glucose production.

Manufacturer: USV Private Limited

• Triple-action glucose control for Type 2 Diabetes.
• Reduces intestinal glucose absorption (Voglibose).
• Stimulates insulin secretion from pancreas (Glimepiride).
• Improves insulin sensitivity and controls hepatic glucose output (Metformin).
• Supports steady blood sugar levels throughout the day.

• Voglibose IP: 0.2 mg
• Glimepiride IP: 2 mg
• Metformin Hydrochloride IP (Sustained Release): 1000 mg
• Colour: Red Oxide of Iron
• Excipients: q.s.

As printed on pack: “Each uncoated bilayered tablet contains Voglibose 0.2 mg, Glimepiride 2 mg, and Metformin Hydrochloride 1000 mg (Sustained Release Form).”

• Take as directed by your physician.
• Swallow the tablet whole with water — do not crush or chew.
• Best taken with meals to prevent hypoglycemia or stomach upset.

Important: Do not crush or chew the tablet. Take the whole tablet with water.

• Storage: Store in a dry place below 30°C. Protect from light and moisture.
• Keep out of reach of children.
• Dispose of expired or unused tablets safely.

• Schedule G & H Prescription Drug: To be sold only on the prescription of a Registered Medical Practitioner.
• Consult your doctor before use if you have kidney, liver, or cardiac disorders.
• Monitor blood sugar levels regularly during treatment.
• Follow a balanced diet and exercise routine as advised.

Disclaimer: For educational and informational purposes only. Always follow your doctor’s advice. Product details may vary as per manufacturer updates.